In December 2025, Amphastar Pharmaceuticals announced that the FDA approved its abbreviated new drug application for a teriparatide injection prefilled pen, deemed bioequivalent and therapeutically ...
Investing.com -- Amphastar Pharmaceuticals (NASDAQ:AMPH) stock gained 2.3% in Monday’s premarket trading after the company announced FDA approval of its teriparatide injection, a generic equivalent to ...
RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbre ...
RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the ...
Get the latest on major stock moves, including iRobot's bankruptcy and key biotech and software sector updates.
In 2022, a woman went to the Skin Beauté Med Spa in Randolph to get injections of a filler meant to plump up her lips — an increasingly popular procedure fueled by social media and beauty influencers.
A Chinese man with no medical training is injecting cancer patients with a toxic bleach solution; a full course of treatment runs $20,000. He’s now working to bring the unproven treatment to the US.
Marie Neidert, 43, first started getting Botox about three years ago as a way to manage her migraines, but enjoyed the cosmetic side effects too. When the medspa she goes to switched to a different ...
Moderna, the biotech company behind one of the original mRNA COVID-19 vaccines, is undergoing an AI-powered workplace transformation. In partnership with OpenAI, Moderna has created thousands of ...
Gold, laser goggles, and a camera: it’s an unlikely combination that could one day be used to restore vision in people with retinal damage, according to researchers. In a new study published in the ...
If you’re prescribed Zepbound, your doctor or another healthcare professional will likely give you the first dose in their office. Then they’ll show you or someone else how to inject your doses at ...